Lonza | LONN - 销售和管理费用





销售和管理费用 更改 日
Akzo Nobel EUR 833M 29M 2026-06
Alcon AG USD 882M 19M 2026-03
AstraZeneca USD 5.8B 735M 2026-06
BASF EUR 2.28B 156M 2026-06
Bayer EUR 3.7B 356M 2026-03
Beiersdorf EUR 271M 51M 2025-12
Covestro EUR 445M 8M 2025-12
Demant DKK 6.09B 135M 2025-12
Fresenius EUR 760M 17M 2026-06
Fresenius Medical Care EUR 749M 36M 2026-03
Geberit CHF 226M 38.6M 2025-03
Genmab DKK 205M 39M 2026-06
Givaudan CHF 561M 25M 2025-12
GlaxoSmithKline GBP 2.19B 75M 2026-06
GN Store Nord DKK 763M 688M 2026-03
Hikma Pharmaceutical USD 288M 149M 2025-12
Johnson Matthey GBP 119M 51M 2026-06
Merck EUR 1.52B 80M 2026-03
Novartis USD 3.24B 101M 2026-06
Philips EUR 1.21B 23M 2026-06
Roche Holding CHF 6.37B 908M 2026-06
Sanofi EUR 2.63B 307M 2026-06
Smith & Nephew USD 1.45B 29M 2026-06
Solvay EUR 123M 8M 2026-06
UCB EUR 1.47B 193M 2025-12